| 摘要 |
FIELD: medicine. ^ SUBSTANCE: application of ibandronic acid or its acceptable salts for production of medical products for treatment of diseases characterised by pathologically bone hyperresorption, especially for osteoporosis prevention and treatment is offered. At that medical product contains 50-250 mg of specified acid or its salt, and it introduced orally within one day per month. Invention provides both decreased bones fragility, and eliminates by-effects of ibandronic acid. ^ EFFECT: development of effective method for bones fragility decrease. ^ 8 cl, 1 ex, 1 tbl |
